• Elotuzumab Combination Disappoints in Newly Diagnosed Myeloma

    10 days ago - By MedPageToday

    Adding the monoclonal antibody elotuzumab to lenalidomide and dexamethasone failed to improve outcomes for patients with newly diagnosed, transplant-ineligible multiple myeloma, a phase III trial showed...
    Read more ...